Thermo Fisher Scientific Advances Cryo-EM Leadership to Drive Structural Biology Discoveries

New Thermo Scientific Krios G3i raises bar for performance, automation and time-to-results Breakthrough Thermo Scientific Glacios provides a cryo-EM entry path for a broader range of researchers ST. LOUIS, Aug. 7, 2017 /PRNewswire/ — Microscopy & Microanalysis 2017 — Thermo Fisher Scientific, the world leader in serving science, has extended its leadership in cryo-electron microscopy (cryo-EM) with the introduction of... Read more

Industry’s First Dedicated Cryo-DualBeam System Automates Preparation of Frozen, Biological Samples

New Thermo Scientific Aquilos FIB/SEM protects sample integrity and enhances productivity for cryo-electron tomography workflow ST. LOUIS, Aug. 7, 2017 /PRNewswire/ — Microscopy & Microanalysis 2017 – The new Thermo Scientific Aquilos is the first commercial cryo-DualBeam (focused ion beam/scanning electron microscope) system dedicated to the preparation of frozen, thin lamella samples from biological specimens for high-resolution tomographic imaging in a... Read more

New Quattro Field Emission ESEM Emphasizes Versatility and Ease of Use

Thermo Scientific Quattro ESEM allows materials science researchers to study nanoscale structure in almost any material under a range of environmental conditions ST. LOUIS, Aug. 7, 2017 /PRNewswire/ — Microscopy & Microanalysis 2017 — The ability of scientists to study samples at the nanometer scale and in natural conditions and environments is critical to the discovery and development of... Read more

Thermo Fisher Extends Cash Tender Offer for All Outstanding Shares of Patheon to Coordinate Offer Timing with Two Remaining Regulatory Approvals

Offer Now Scheduled to Expire at 5:00 p.m., New York City Time, on August 28, 2017 WALTHAM, Mass., Aug. 7, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that its wholly owned subsidiary, Thermo Fisher (CN) Luxembourg S.à r.l., has extended the offering period of its previously announced all-cash tender offer to... Read more

Thermo Fisher Scientific Announces $1.5 Billion Offering of Common Stock

WALTHAM, Mass., Aug. 7, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it has commenced an underwritten public offering of $1.5 billion of its common stock. Thermo Fisher also intends to grant the underwriters an option for a period of 30 days to purchase up to $225.0 million of additional shares of its common stock. All of the shares in the... Read more

Natural Killer Cells: Cultivation, Activation and Growth Miltenyi Biotec extends its product portfolio in the area of cell culture media with the NK MACS® Medium

BERGISCH GLADBACH, August 3, 2017 – A new addition to the well-known product family of cell culture media: With the new NK MACS® Medium, human, Miltenyi Biotec offers a product to improve the cultivation of human natural killer cells, or NK cells as they are called. The biotechnology company from Bergisch Gladbach, already known as a... Read more

BASi Announces Election of R. Matthew Neff to the Board of Directors

PRESS RELEASE  UPDATED: AUG 3, 2017 08:33 EDT WEST LAFAYETTE, IN, August 3, 2017 (Newswire.com) – Bioanalytical Systems, Inc. (NASDAQ: BASI) (“BASi” or the “Company”) today announced that its Board of Directors unanimously elected R. Matthew Neff, as a director, effective August 1, 2017.  “We are pleased to welcome Mr. Neff to the Board and look forward to... Read more

FDA Issues Emergency Use Authorization for Thermo Fisher Scientific’s Zika Virus Assay

CARLSBAD, Calif., Aug. 3, 2017 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization for the company’s new TaqPath Zika Virus Kit. The TaqPath Zika Virus Kit is authorized only for the qualitative detection of RNA from Zika virus and... Read more

Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run

Revolutionary technology will accelerate utility of gene mapping, biomarker discovery, tumor profiling, and liquid biopsy analysis (ANN ARBOR, Mich. – August 3, 2017) Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the launch of Accel-NGS® 2S Indexed Adapters, a new portfolio of indices that significantly improves multiplexed next-generation sequencing on... Read more